A journal article by Thomas LeBlanc, MD, associate professor of medicine (Hematologic Malignancies and Cellular Therapy), and Amy Abernethy, MD, adjunct professor of medicine (Medical Oncology), has been recognized as a paper that could "Change the World, One Article At A Time" by Springer Nature journals.
Department of Medicine faculty, trainees and staff received seven of 10 2018 DIHI Innovation Awards, which support high-potential care delivery innovation projects in the areas of population health and analytics, novel patient interactions, new and team-based models of care, and optimization of patient flow.
Department of Medicine faculty are attending the American Society of Hematology's (ASH) 59th Annual Meeting & Exposition in Atlanta this week. Keep reading for highlights on their research.
Tom LeBlanc, MD, MA, assistant professor of medicine (Hematological Malignancies and Cellular Therapy) and member of Duke Cancer Institute, has been invited to present at the National Comprehensive Cancer Network's 11th Annual Congress: Hematological Malignancies on Oct. 1.
Arif Kamal, MD, MBA, assistant professor of medicine (Medical Oncology), and
Three Department of Medicine faculty will serve as featured voices on Twitter for the American Soc
Arif Kamal, MD, assistant professor of medicine (Medical Oncology), recently earned the designation Fellow of the American Academy of Hospice and Palliative Medicine.
The American Academy of Hospice and Palliative Medicine, the largest and most influential palliative care physician membership organization in the